Dana H. Shin

Array ( [id] => 11936754 [patent_doc_number] => 20170240904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-24 [patent_title] => 'SPLICE MODULATING OLIGONUCLEOTIDES AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/504952 [patent_app_country] => US [patent_app_date] => 2015-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 28901 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15504952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822411 [patent_doc_number] => 20160168575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'ANTISENSE DESIGN' [patent_app_type] => utility [patent_app_number] => 14/882366 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19536 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882366 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10822412 [patent_doc_number] => 20160168576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'ANTISENSE DESIGN' [patent_app_type] => utility [patent_app_number] => 14/882369 [patent_app_country] => US [patent_app_date] => 2015-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 19506 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14882369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15481389 [patent_doc_number] => 10556020 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => RNA-modulating agents [patent_app_type] => utility [patent_app_number] => 14/866186 [patent_app_country] => US [patent_app_date] => 2015-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 22 [patent_no_of_words] => 17061 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14866186 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11979649 [patent_doc_number] => 20170283804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'ANTISENSE COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/510750 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47284 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14119715 [patent_doc_number] => 10246707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means [patent_app_type] => utility [patent_app_number] => 14/859598 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 15375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14859598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12126541 [patent_doc_number] => 20180010126 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'ANTISENSE COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/510993 [patent_app_country] => US [patent_app_date] => 2015-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41986 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10714480 [patent_doc_number] => 20160060627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-03-03 [patent_title] => 'Pharmaceutical Composition for Inhibition of Disease-inducing microRNAs' [patent_app_type] => utility [patent_app_number] => 14/844088 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 42638 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13354579 [patent_doc_number] => 20180228829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS [patent_app_type] => utility [patent_app_number] => 15/508785 [patent_app_country] => US [patent_app_date] => 2015-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24779 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13604433 [patent_doc_number] => 20180353765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => MAGNETOGENETICS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/756554 [patent_app_country] => US [patent_app_date] => 2015-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11520 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15756554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11994202 [patent_doc_number] => 20170298357 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'Treatment of HIV' [patent_app_type] => utility [patent_app_number] => 15/507308 [patent_app_country] => US [patent_app_date] => 2015-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14958 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 58 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507308 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491649 [patent_doc_number] => 20150376670 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'DNA TEMPLATES FOR SMALL RNA PRODUCTION IN MAMMALIAN CELLS' [patent_app_type] => utility [patent_app_number] => 14/832118 [patent_app_country] => US [patent_app_date] => 2015-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 21085 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10700788 [patent_doc_number] => 20160046935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-18 [patent_title] => 'Micrornas And Uses Thereof' [patent_app_type] => utility [patent_app_number] => 14/756185 [patent_app_country] => US [patent_app_date] => 2015-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15300 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14756185 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10444859 [patent_doc_number] => 20150329873 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'FURIN-KNOCKDOWN AND GM-CSF-AUGMENTED (FANG) CANCER VACCINE' [patent_app_type] => utility [patent_app_number] => 14/815721 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17629 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14815721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14485603 [patent_doc_number] => 10329570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-25 [patent_title] => Antagonistic PD-1 aptamer and its applications in cancer therapy related applications [patent_app_type] => utility [patent_app_number] => 15/500354 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 17 [patent_no_of_words] => 11232 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15102649 [patent_doc_number] => 10472626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-12 [patent_title] => Modified antimir-138 oligonucleotides [patent_app_type] => utility [patent_app_number] => 15/500022 [patent_app_country] => US [patent_app_date] => 2015-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 27 [patent_no_of_words] => 15510 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15500022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17251396 [patent_doc_number] => 11186873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-30 [patent_title] => Combination method for treating cancer by targeting immunoglobulin superfamily member 1 (IGSF1) and mesenchymal-epithelial transition factor (MET) [patent_app_type] => utility [patent_app_number] => 15/329904 [patent_app_country] => US [patent_app_date] => 2015-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 10501 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521881 [patent_doc_number] => 09605266 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Cell-specific internalizing RNA aptamers against human CCR5 and uses therefore' [patent_app_type] => utility [patent_app_number] => 14/801710 [patent_app_country] => US [patent_app_date] => 2015-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 39 [patent_no_of_words] => 29136 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14801710 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12527553 [patent_doc_number] => 10006030 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => RNA interference compositions targeting heat shock protein 90 and methods of use thereof [patent_app_type] => utility [patent_app_number] => 15/326044 [patent_app_country] => US [patent_app_date] => 2015-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 10058 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15326044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11122302 [patent_doc_number] => 20160319276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-11-03 [patent_title] => 'Novel non-coding RNA, cancer target and compounds for cancer treatment' [patent_app_type] => utility [patent_app_number] => 14/797148 [patent_app_country] => US [patent_app_date] => 2015-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12875 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14797148 [rel_patent_id] =>[rel_patent_doc_number] =>)